Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer

Abstract

Recent studies revealed that ethnic differences in mechanistic target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK-1/2) signaling pathways might be associated with the development and progression of different human malignancies. The African American (AA) population has an increased rate of cancer incidence and mortality compared to the Caucasian American (CA) population. Although the socioeconomic differences across different ethnic groups contribute to the disparity in developing different cancers, recent scientific evidence indicates the association of molecular and genetic variations in racial disparities of different human malignancies. The mTOR and ERK-1/2 signaling pathways are one of the well-known oncogenic signaling mechanisms that regulate diverse molecular and phenotypic aspects of normal as well as cancer cells in response to different external or internal stimuli. To date, very few studies have been carried out to explore the significance of racial disparity with abnormal mTOR and ERK-1/2 kinase signaling pathways, which may contribute to the development of aggressive human cancers. In this review, we discuss the differential regulation of mTOR and ERK-1/2 kinase signaling pathways across different ethnic groups, especially between AA and CA populations. Notably, we observed that key signaling proteins associated with mTOR and ERK-1/2 pathway including transforming growth factor-beta (TGF-β), Akt, and VEGFR showed racially disparate expression in cancer patients. Overall, this review article encompasses the significance of racially disparate signaling molecules related to mTOR/ERK1/2 and their potential in developing tailor-made anti-cancer therapies.

ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma

“…However, few targeted therapies are aimed against the specific regulatory machinery that drives entry and progression throughout the cell division cycle [ 25 ]. The MAPK signaling cascade is a highly evolutionarily conserved signaling pathway that participates in a myriad of cellular functions, including cell survival, proliferation, growth, and apoptosis [ 26 , 27 ]. As shown in previous results, ANKFN1 can promote HCC cell proliferation.…”

Biological role and expression of translationally controlled tumor protein (TCTP) in tumorigenesis and development and its potential for targeted tumor therapy

“…The signaling pathways of mTORC1 primarily involve positive regulation by the PI3K/AKT pathway and negative regulation by the adenosine monophosphate-activated protein kinase (AMPK) pathway [35][36][37][38]. Additionally, the activated receptor Ras signaling pathway can activate ERK and inhibit TSC, ultimately resulting in the activation of mTORC1 [39,40].…”